Flint, O. P., Noor, M. A., Hruz, P. W., Hylemon, P. B., Yarasheski, K., Kotler, D. P., . . . Bellamine, A. (2009). The Role of Protease Inhibitors in the Pathogenesis of HIV-Associated Lipodystrophy: Cellular Mechanisms and Clinical Implications.
Chicago Style CitationFlint, Oliver P., Mustafa A. Noor, Paul W. Hruz, Phil B. Hylemon, Kevin Yarasheski, Donald P. Kotler, Rex A. Parker, i Aouatef Bellamine. The Role of Protease Inhibitors in the Pathogenesis of HIV-Associated Lipodystrophy: Cellular Mechanisms and Clinical Implications. 2009.
Cita MLAFlint, Oliver P., et al. The Role of Protease Inhibitors in the Pathogenesis of HIV-Associated Lipodystrophy: Cellular Mechanisms and Clinical Implications. 2009.
Atenció: Aquestes cites poden no estar 100% correctes.